In an impressive achievement,
Fatty15 has claimed the title of
Best Cellular Health Supplement Brand 2026 in the USA, as awarded by
Global Health Pharma (GHP). This recognition underscores the essential role of
strong cellular health in promoting overall wellness, emphasizing that robust cells contribute significantly to metabolic, immune, and cognitive functions.
The hallmark of Fatty15's success lies in its unique formulation of
C150 (pentadecanoic acid), which is touted as the first new essential fatty acid identified in over ninety years. Scientific literature increasingly suggests that inadequate levels of C150 can lead to
ferroptosis, a newly identified type of cellular death that accelerates aging and adversely affects various health aspects, including liver and heart function. Fatty15 stands apart in the supplement industry not just for its distinct offerings but also for its robust scientific backing, boasting over 150 peer-reviewed studies that validate its claims.
C150 is known for promoting a host of cellular benefits — more than 36 distinct advantages, to be precise. These include improvements in metabolic health, cognitive function, and red blood cell health. By actively engaging with key cellular pathways, C150 supports cellular resilience against age-related decline, activating
AMPK while inhibiting
mTOR, pathways that are crucial for longevity. Furthermore, it aids in repairing mitochondrial function, which tends to decline with age.
The GHP award reflects not only the scientific underpinnings of Fatty15 but also its considerable impact on users. Based on a survey of over 6,200 consumers, 70% reported perceivable benefits within just 16 weeks of use. Additionally, the brand boasts an impressive
95% monthly customer retention rate since its inception in 2021, with over 110,000 active subscribers. In early 2026, Fatty15 also received the
TESTED by SuppCo Certification, achieving an excellent
TrustScore of 9.88, placing it firmly within the top 1% of over 160,000 supplements evaluated.
Dr.
Eric Venn-Watson, co-founder and co-CEO of
Seraphina Therapeutics, voiced the importance of C150 in maintaining cellular integrity. He noted that recent studies substantiate that deficiencies in nutritional C150 could exacerbate cellular aging. The latest accolade for Fatty15 signifies not only the growing acknowledgment within the industry but also the global initiative to enhance well-being from the cellular level upwards.
This new accolade adds to Fatty15's expanding collection of awards, which include the
GHP Global Excellence Award as the Best Longevity Supplement Brand of 2025, the
Best Essential Fatty Acid Supplement Brand 2026, and the
Mindful Award's Wellness Company of the Year 2026. Moreover, Seraphina Therapeutics has been recognized as the
#1 fastest-growing supplement company in the 2025
Inc. 5000 list, illustrating its significant impact and growth trajectory.
About Seraphina Therapeutics: This innovative health and wellness company is dedicated to enhancing global health through the formulation of
essential nutrients and longevity-supporting compounds, including its award-winning
C150 supplement. Backed by a team of leading scientists, Seraphina Therapeutics is determined to redefine nutritional strategies, paving the way for breakthrough health products aimed at improving quality of life often lost over time. For further information, visit
DiscoverC15.com and
fatty15.com.
These claims have not been evaluated by the FDA. This product is not intended for the diagnosis, treatment, cure, or prevention of any disease.